252 related articles for article (PubMed ID: 30401548)
1. Cardiovascular Implications of the Menopause Transition: Endogenous Sex Hormones and Vasomotor Symptoms.
El Khoudary SR; Thurston RC
Obstet Gynecol Clin North Am; 2018 Dec; 45(4):641-661. PubMed ID: 30401548
[TBL] [Abstract][Full Text] [Related]
2. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
El Khoudary SR
Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
[TBL] [Abstract][Full Text] [Related]
3. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
Thurston RC; Sowers MR; Chang Y; Sternfeld B; Gold EB; Johnston JM; Matthews KA
Am J Epidemiol; 2008 Jan; 167(1):78-85. PubMed ID: 17881385
[TBL] [Abstract][Full Text] [Related]
4. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
Deecher DC; Dorries K
Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
[TBL] [Abstract][Full Text] [Related]
5. Vasomotor symptoms and cardiovascular disease risk.
Pines A
Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
[TBL] [Abstract][Full Text] [Related]
6. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN.
Thurston RC; Aslanidou Vlachos HE; Derby CA; Jackson EA; Brooks MM; Matthews KA; Harlow S; Joffe H; El Khoudary SR
J Am Heart Assoc; 2021 Feb; 10(3):e017416. PubMed ID: 33470142
[TBL] [Abstract][Full Text] [Related]
7. Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.
Avis NE; Crawford SL; Green R
Obstet Gynecol Clin North Am; 2018 Dec; 45(4):629-640. PubMed ID: 30401547
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.
Thurston RC
Climacteric; 2018 Apr; 21(2):96-100. PubMed ID: 29390899
[TBL] [Abstract][Full Text] [Related]
9. Menopause: evidence-based practice.
Blake J
Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and nonhormonal treatment of vasomotor symptoms.
Krause MS; Nakajima ST
Obstet Gynecol Clin North Am; 2015 Mar; 42(1):163-79. PubMed ID: 25681847
[TBL] [Abstract][Full Text] [Related]
11. Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms.
Allshouse A; Pavlovic J; Santoro N
Obstet Gynecol Clin North Am; 2018 Dec; 45(4):613-628. PubMed ID: 30401546
[TBL] [Abstract][Full Text] [Related]
12. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause.
Ford K; Sowers M; Crutchfield M; Wilson A; Jannausch M
Menopause; 2005; 12(3):308-17. PubMed ID: 15879920
[TBL] [Abstract][Full Text] [Related]
14. Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study.
El Khoudary SR; Nasr A; Billheimer J; Brooks MM; McConnell D; Crawford S; Orchard TJ; Rader DJ; Matthews KA
J Clin Endocrinol Metab; 2022 Jan; 107(1):e303-e314. PubMed ID: 34390340
[TBL] [Abstract][Full Text] [Related]
15. Vasomotor symptoms and lipid profiles in women transitioning through menopause.
Thurston RC; El Khoudary SR; Sutton-Tyrrell K; Crandall CJ; Gold EB; Sternfeld B; Joffe H; Selzer F; Matthews KA
Obstet Gynecol; 2012 Apr; 119(4):753-61. PubMed ID: 22433339
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning Approaches to Identify Factors Associated with Women's Vasomotor Symptoms Using General Hospital Data.
Ryu KJ; Yi KW; Kim YJ; Shin JH; Hur JY; Kim T; Seo JB; Lee KS; Park H
J Korean Med Sci; 2021 May; 36(17):e122. PubMed ID: 33942581
[TBL] [Abstract][Full Text] [Related]
17. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
Zhu D; Li X; Macrae VE; Simoncini T; Fu X
Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
19. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?
Biglia N; Cagnacci A; Gambacciani M; Lello S; Maffei S; Nappi RE
Climacteric; 2017 Aug; 20(4):306-312. PubMed ID: 28453310
[TBL] [Abstract][Full Text] [Related]
20. Obesity and menopause.
Al-Safi ZA; Polotsky AJ
Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):548-53. PubMed ID: 25579233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
